Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
British Journal of Cancer
|
December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
A Horwich, R T Oliver, P M Wilkinson, et al.
British Journal of Cancer
|
July 22, 2004
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
A J Clayton, S Danson, S Jolly, et al.
Cancer
|
October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
S P Stenning, M C Parkinson, C Fisher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center
R E Board, C T P H Bruijns, A E Pronk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer
A Weaver, J Chang, E Wrigley, et al.
British Journal of Cancer
|
July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
S D Fosså, S P Stenning, A Gerl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease
J A Radford, A Z S Rohatiner, W D J Ryder, et al.
British Journal of Cancer
|
December 4, 1998
Chemotherapy for ovarian cancer--a consensus statement on standard practice
M Adams, A H Calvert, J Carmichael, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
British Journal of Cancer
|
December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
A Horwich, R T Oliver, P M Wilkinson, et al.
British Journal of Cancer
|
July 22, 2004
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
A J Clayton, S Danson, S Jolly, et al.
Cancer
|
October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
S P Stenning, M C Parkinson, C Fisher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center
R E Board, C T P H Bruijns, A E Pronk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer
A Weaver, J Chang, E Wrigley, et al.
British Journal of Cancer
|
July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
S D Fosså, S P Stenning, A Gerl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease
J A Radford, A Z S Rohatiner, W D J Ryder, et al.
British Journal of Cancer
|
December 4, 1998
Chemotherapy for ovarian cancer--a consensus statement on standard practice
M Adams, A H Calvert, J Carmichael, et al.
Page
of 8